‡a
rasbrafcirculatingtumordnamutationsasapredictorofresponseto1linechemotherapyinmetastaticcolorectalcancerpatients
‡A
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
‡9
1